• Services

    Services

    Inoviem provides a full range of services from drug discovery to clinical development by leveraging its platforms and direct access to human pathological specimens. All the platforms and services are label free with no modification of the original molecules.

    Understand the mode of action of your compound

    Identify and validate drug-target engagement

    Lead compound optimization

    Patient stratification and biomarkers discovery

    Indication prioritization

    Identify biomarkers and clinical pharmacology

    SPR services 

    MoA Screening

  • Technology

    Technology

    Inoviem provides breakthrough protein technologies for each phase of the drug development process.
    One of the major advantages of our label-free technologies used under physiological conditions and in human tissue – NPOT® and PIMS® – is that the test compound retains its original structure, as well as the exact same molecular structure that would be used in therapy

    Preclinical

    How to best identify the Mode of Action of your compound

    Read more

    From preclinical to clinical

    Ensure Phase II study and success of your drug candidate in Phase III

    Read more

    Clinical

    Successfully identify the cohort of patients who will respond to your therapy

    Read more

  • Expertise

    Our expertise in translational pharmacology

    Inoviem offers translational target discovery and drug-target Mode of Action (MoA) based on proprietary label-free technologies, developed in a pathological and physiological environment, that uses human tissue.

    Translational pharmacology expertise

    Pre-clinical to clinical phases

    Read more

    Our innovative approach

    Biomarkers, patient and therapeutic window

    Read more

    Advantages of approach

    Save time and money

    Read more

    How we work with clients

    Tailored methodologies and technologies 

    Read more

  • Knowledge centre
  • About us

    About us

    Inoviem Scientific is a Bioanalytical R&D company established in 2011 in Strasburg – France.

    Our mission

    Our mission is clear: to get the right treatment to the right patients within the right therapeutic window.

    Read more

    Our team

    • Management team
    • Scientific board
    • Supervisory board & investors

    Read more

  • Contact us

Services

Inoviem Scientific offers a range of services tailored to the needs of drug discovery, preclinical and clinical development. We help researchers better meet all the key requirements to validate an experiment, accelerate drug development or achieve clinical trial objectives.

Understand
the Mode of Action of your compound

The ultimate understanding of the Mode of Action (MoA) of your compound with a patient centric approach.

Identify and validate drug-target engagement

Our robust empirical approach enables you to validate targets in a study model, identify secondary targets and validate a target engagement in a targeted organism.

Lead compound optimization

With greater emphasis on translational pharmacology, any number of compounds can be profiled, and we can identify within four weeks of study which one of these offers the best ‘druggability’ to move forward into development.

Patient stratification and biomarkers
discovery

Inoviem identifies the patient subset that will best respond to the compound by challenging patient material with drug in development.

Idendication prioritization

Should your promising compound fail in its primary indication, we can fast-track you to identifying a more efficient indication.

Identify biomarkers and clinical pharmacology

Inoviem’s translational pharmacology approaches empower your ability to identify promising biomarkers and advance clinical developments.

SPR

Inoviem Scientific provides Surface Plasmon Resonance (SPR) services to analyze the interactions of two biomolecules with respect to binding kinetics and affinity as well as binding specificity.

Mode of Action Screening

MoA Screening is our latest label free service platform designed to rapidly identify ON/OFF targets and signaling pathways triggered by compounds in physiological and pathological conditions.

Headquarter
Bioparc 2, 850 boulevard Sébastien Brant,
67400 Illkirch-Graffenstaden

CONTACT US


SERVICES
EXPERTISE

Our expertise in translational pharmacology
Advantages of a translational pharmacology approach
How we work with clients

TECHNOLOGY

Preclinical
From preclinical to clinical
Clinical

RESOURCES
ABOUT US

Our mission
Our team

PRIVACY POLICY
Need Help